It can collaborate with TRAIL to stimulate apoptosis in colon cancer, NSCLC, glioma, and several other cancerous cells through two approaches, by increasing the DR5 expression, and by preventing the expression of surviving [93,94]. This evidence concerns the gene TNFRSF10B and glioma.